Sunshine Biopharma (SBFM) Enterprise Value (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Enterprise Value came in at -$6.9 million in Q1 2026, up 15.64% YoY from -$6.0 million in Q1 2025, and up 24.23% on a QoQ basis from -$9.1 million in Q4 2025.
Sunshine Biopharma (SBFM) Enterprise Value (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Enterprise Value data on file, last reported at -$6.9 million in Q1 2026.
- Quarterly Enterprise Value rose 15.64% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (up 15.64% YoY) and the FY2025 annual result came in at -$9.1 million, up 5.81% from the prior year.
- Enterprise Value advanced to -$6.9 million in Q1 2026, from -$9.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$6.9 million in Q1 2026 to a low of -$41.7 million in Q2 2022.
- A 5-year average of -$16.8 million and a median of -$13.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 2294.89% — and 2023, when it jumped 53.54%.
- Tracing SBFM's Enterprise Value over 5 years: stood at -$21.8 million in 2022, then gained by 25.35% to -$16.3 million in 2023, then surged by 40.55% to -$9.7 million in 2024, then climbed by 5.81% to -$9.1 million in 2025, then gained by 24.23% to -$6.9 million in 2026.
- The last three Enterprise Value figures came in at -$6.9 million (Q1 2026), -$9.1 million (Q4 2025), and -$9.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -13.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.75 Mn |
| Mar 31, 2026 | -6.91 Mn |
| Dec 31, 2025 | -9.12 Mn |
| Sep 30, 2025 | -9.31 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Mar 31, 2025 | -8.20 Mn |
| Dec 31, 2024 | -9.69 Mn |
| Sep 30, 2024 | -12.21 Mn |
| Jun 30, 2024 | -11.51 Mn |
| Mar 31, 2024 | -17.43 Mn |
| Dec 31, 2023 | -16.29 Mn |
| Sep 30, 2023 | -18.85 Mn |
| Jun 30, 2023 | -19.73 Mn |
| Mar 31, 2023 | -19.29 Mn |
| Dec 31, 2022 | -21.83 Mn |
| Sep 30, 2022 | -40.56 Mn |
| Jun 30, 2022 | -41.74 Mn |
| Mar 31, 2022 | -13.19 Mn |
| Dec 31, 2021 | -2.05 Mn |
| Sep 30, 2021 | -2.39 Mn |